The Anaphylaxis Campaign has received the following updated statement from Mylan regarding the availability of EpiPen. This includes information for patients, prescribers, pharmacists, hospitals and schools. Mylan’s manufacturing partner Meridian Medical Technologies,…
Read more
The Anaphylaxis Campaign is saddened to learn of the death of Sam Collings, aged 19, who died at Bolton Hospital on the 4th August 2019. According to media reports, neither Sam or…
Read more
The Anaphylaxis Campaign is delighted to hear about the success of Aimmune Therapeutics, Inc. in the approval of their oral immunotherapy drug, Palforzia, by the US Food and Drug Administration (FDA). This…
Read more
An editorial in the February edition of Clinical and Experimental Allergy (the official journal of the British Society of Allergy and Clinical Immunology) explores the current statutory guidance on the care of…
Read more
Biopharmaceutical company DBV Technologies has announced positive results from its Viaskin® Peanut trial into reducing the risk of allergic reaction in children aged 4 to 11. Viaskin is a patch applied directly…
Read more
The Anaphylaxis Campaign has received and has been asked to share the following update from Sacla regarding its recent pesto recall. Update from Sacla: Customer health and safety is always our number one…
Read more
The Coroner has ended the inquest into the death of Shante Turay-Thomas and has delivered her narrative determination and the Prevention of Future Deaths report. The Anaphylaxis Campaign would like to extend…
Read more
The Anaphylaxis Campaign is saddened to learn of the death of Ken Matthews, 84, who died at Wrexham Maelor Hospital on 2 June 2019. Consultant pathologist Dr Huyen Abdel Salam told the…
Read more
The Artichoke, Croxley Green, has been fined £23,000 after being prosecuted by Hertfordshire Trading Standards when one of its customers became seriously ill. Hertfordshire County Council said KOB (The Artichoke) Ltd pleaded…
Read more